Deerfield Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Deerfield Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-333,333	Closed	-$543K	–	638
2024 Q2	$543K	Hold	333,333	–	–	0.01%	244
2024 Q1	$333K	Hold	333,333	–	–	0.01%	232
2023 Q4	$397K	Hold	333,333	–	–	0.01%	90
2023 Q3	$127K	Hold	333,333	–	–	﹤0.01%	79
2023 Q2	$14K	Hold	333,333	–	–	﹤0.01%	99
2023 Q1	$20.5K	Hold	333,333	–	–	﹤0.01%	99
2022 Q4	$25K	Hold	333,333	–	–	﹤0.01%	99
2022 Q3	$20K	Hold	333,333	–	–	﹤0.01%	120
2022 Q2	$28K	Hold	333,333	–	–	﹤0.01%	120
2022 Q1	$85K	Hold	333,333	–	–	﹤0.01%	113
2021 Q4	$174K	Hold	333,333	–	–	﹤0.01%	122
2021 Q3	$273K	Buy	+333,333	New	+$309K	0.01%	128

Other funds holding TLSIW

Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

FVWA

Foster Victor Wealth Advisors Greenville, South Carolina $1.75B AUM 18.02% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

ACM

Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Deerfield Management's TLSIW Position: Q3 2024 in Review

Deerfield Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2024, closing a stake of 333,333 shares — an estimated $543K sold.

Deerfield Management first reported a position in TLSIW in Q3 2021 and held it in 12 quarters. The position peaked at $543K in Q2 2024. 8 funds tracked by Wall St. Rank hold TLSIW as of Q3 2024.

Deerfield Management reported no remaining TriSalus Life Sciences Warrant position as of Q3 2024 after selling out during the quarter.
Deerfield Management sold 333,333 TriSalus Life Sciences Warrant shares in Q3 2024, an estimated $543K.
Deerfield Management first reported a position in TriSalus Life Sciences Warrant in Q3 2021 and held it in 12 quarters.
Deerfield Management's TriSalus Life Sciences Warrant position peaked at $543K in Q2 2024.
8 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2024.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.